Sibold William John

Insider profile

Performance

Overall performance
2.6

Performance over holding periods
2.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Sibold William John's trades of Madrigal Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-06 2026-03-06 S Sale
16,295 -43.6%
354.11
US$4,370,768
16,295 -43.6% 354.11 US$4,370,768
2026-03-06 2026-03-06 PrS Proposed sale
14,938
224.03
US$553,181
14,938 224.03 US$553,181
2026-01-26 2026-01-26 PrS Proposed sale
29,768
312.34
US$775,446
29,768 312.34 US$775,446
2026-01-26 2026-01-26 S Sale
1,577 -1.1%
492.42
US$776,546
1,577 -1.1% 492.42 US$776,546
2025-12-04 2025-12-04 PrS Proposed sale
2,400
579.89
US$1,391,736
2,400 579.89 US$1,391,736
2025-12-04 2025-12-04 S Sale
2,400 -1.6%
575.34
US$1,380,816
2,400 -1.6% 575.34 US$1,380,816
2025-09-09 2025-09-09 PrS Proposed sale
7,279
453.80
US$3,303,210
7,279 453.80 US$3,303,210
2025-09-09 2025-09-09 S Sale
7,279 -6.6%
445.63
US$3,243,741
7,279 -6.6% 445.63 US$3,243,741
2025-08-21 2025-08-21 PrS Proposed sale
7,616
391.66
US$2,982,883
7,616 391.66 US$2,982,883
2025-08-21 2025-08-21 PlS Planned sale
1,131 -1.0%
401.00
US$453,531
1,131 -1.0% 401.00 US$453,531
2025-08-21 2025-08-21 PlS Planned sale
6,485 -5.5%
400.03
US$2,594,225
6,485 -5.5% 400.03 US$2,594,225
2025-01-27 2025-01-24 S Sale
1,584 -2.8%
335.24
US$531,020
1,584 -2.8% 335.24 US$531,020
2025-01-24 2025-01-24 PrS Proposed sale
1,584
340.14
US$538,782
1,584 340.14 US$538,782
2024-09-11 2024-09-09 S Sale
6,363 -10.2%
243.83
US$1,551,490
6,363 -10.2% 243.83 US$1,551,490
2024-09-10 2024-09-09 PrS Proposed sale
6,363
243.83
US$1,551,514
6,363 243.83 US$1,551,514